Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Unknown 11Completed 9Terminated 5Recruiting 4Suspended 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Breast Neoplasms 13Brain Neoplasms 9Prostatic Neoplasms 7Neoplasms 7Head and Neck Neoplasms 6Motor Activity 4Glioma 4Glioblastoma 4Triple Negative Breast Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pain 3Colorectal Neoplasms 3Quality of Life 2Papillomavirus Infections 2Pancreatic Neoplasms 2Obesity 2Multiple Myeloma 2Melanoma 2Lymphoma, Follicular 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Depression 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Cancer Pain 2Biliary Tract Neoplasms 2Behavior 2Weight Loss 1Venous Thromboembolism 1Ureteral Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Suspended × Gastrointestinal Stromal Tumors × Clear all
NCT02924714 2022-02-18

SSG XXV: The Stop-GIST Trial; Discontinuation of Imatinib in Patients With Oligo-metastatic GIST

Oslo University Hospital

Phase NA Suspended
31 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡